# Allurion Technologies Inc. (ALUR)

Source: https://www.quantisnow.com/company/ALUR
Generated: 2026-11-15T04:44:29.745Z

- Ticker: ALUR
- Exchange: NYSE
- Sector: Health Care
- Industry: Medical/Dental Instruments
- SEC CIK: 0001964979

## Latest ALUR news and filings

- 2026-10-13 15:03 UTC [SEC Form 25-NSE filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-allurion-technologies-inc-6744728)
- 2026-09-03 00:03 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-allurion-technologies-inc-6703930)
- 2026-08-24 21:30 UTC [SEC Form 8-K] [Allurion Technologies Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/allurion-technologies-inc-filed-sec-form-8-k-leadership-update-6693156)
- 2026-08-14 21:00 UTC [SEC Form NT 10-Q filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-allurion-technologies-inc-6683570)
- 2026-07-24 20:50 UTC [SEC Form 8-K] [Allurion Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/allurion-technologies-inc-filed-sec-form-8-k-entry-into-a-6648549)
- 2026-07-23 21:19 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-allurion-technologies-inc-6647520)
- 2026-07-23 21:10 UTC [SEC Form 4] [Large owner Rtw Investments, Lp disposed of 392,766 shares (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-rtw-investments-lp-disposed-of-392766-shares-sec-6647486)
- 2026-07-23 21:00 UTC [SEC Form 8-K] [Allurion Technologies Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/allurion-technologies-inc-filed-sec-form-8-k-leadership-update-6647444)
- 2026-07-07 12:05 UTC [SEC Form 8-K] [Allurion Technologies Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/allurion-technologies-inc-filed-sec-form-8-k-leadership-update-6629514)
- 2026-06-30 21:00 UTC [SEC Form 8-K] [Allurion Technologies Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/allurion-technologies-inc-filed-sec-form-8-k-leadership-update-6621184)
- 2026-06-17 20:35 UTC [SEC Form 8-K] [Allurion Technologies Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/allurion-technologies-inc-filed-sec-form-8-k-material-modification-to-6606986)
- 2026-06-17 20:05 UTC [Allurion Advances Plan to Re-List](https://www.quantisnow.com/insight/allurion-advances-plan-to-re-list-6606509)
- 2026-06-02 13:00 UTC [Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum](https://www.quantisnow.com/insight/allurion-announces-strong-start-to-us-launch-with-exceptional-early-6583518)
- 2026-05-27 20:35 UTC [SEC Form 8-K] [Allurion Technologies Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/allurion-technologies-inc-filed-sec-form-8-k-changes-in-registrants-6575162)
- 2026-03-30 12:30 UTC [SEC Form 10-K] [SEC Form 10-K filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-allurion-technologies-inc-6476079)
- 2026-03-12 21:11 UTC [SEC Form 8-K] [Allurion Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/allurion-technologies-inc-filed-sec-form-8-k-notice-of-delisting-6445318)
- 2026-03-02 21:20 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-allurion-technologies-inc-6422101)
- 2026-03-02 14:18 UTC [SEC Form 8-K] [SEC Form 8-K filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-allurion-technologies-inc-6421197)
- 2026-03-02 14:00 UTC [Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE](https://www.quantisnow.com/insight/allurion-intends-to-appeal-nyse-notice-of-delisting-execute-plan-6421095)
- 2026-02-25 13:30 UTC [SEC Form 8-K] [Allurion Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/allurion-technologies-inc-filed-sec-form-8-k-entry-into-a-6412082)
- 2026-02-24 14:15 UTC [Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds](https://www.quantisnow.com/insight/allurion-announces-exercise-of-warrants-for-30-million-in-gross-6409195)
- 2026-02-23 14:06 UTC [SEC Form 8-K] [Allurion Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/allurion-technologies-inc-filed-sec-form-8-k-regulation-fd-disclosure-6406446)
- 2026-02-23 14:00 UTC [Allurion Receives U.S. FDA Approval](https://www.quantisnow.com/insight/allurion-receives-us-fda-approval-6406424)
- 2026-02-17 22:10 UTC [SEC Form 5] [Gibbons Brendan M. decreased direct ownership by 15% to 10,408 units (SEC Form 5)](https://www.quantisnow.com/insight/gibbons-brendan-m-decreased-direct-ownership-by-15-to-10408-6397065)
- 2026-02-17 22:09 UTC [SEC Form 5] [Buch Ojas decreased direct ownership by 17% to 10,223 units (SEC Form 5)](https://www.quantisnow.com/insight/buch-ojas-decreased-direct-ownership-by-17-to-10223-units-6397053)
- 2026-02-03 14:00 UTC [Allurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted Prices](https://www.quantisnow.com/insight/allurion-announces-partnership-to-offer-combination-therapy-with-mounjaro-tirzepatide-6371540)
- 2026-01-20 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-allurion-technologies-inc-6352984)
- 2026-01-12 21:30 UTC [SEC Form 8-K] [Allurion Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/allurion-technologies-inc-filed-sec-form-8-k-results-of-operations-6346612)
- 2026-01-12 13:30 UTC [Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results](https://www.quantisnow.com/insight/allurion-announces-preliminary-fourth-quarter-and-full-year-2025-results-6345792)
- 2026-01-09 22:24 UTC [SEC Form S-3] [SEC Form S-3 filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-allurion-technologies-inc-6344810)
- 2025-12-31 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-allurion-technologies-inc-6330424)
- 2025-12-29 21:05 UTC [SEC Form POS AM filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-allurion-technologies-inc-6328484)
- 2025-12-22 13:27 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-allurion-technologies-inc-6324808)
- 2025-12-22 13:26 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-allurion-technologies-inc-6324807)
- 2025-12-19 22:00 UTC [SEC Form 8-K] [Allurion Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/allurion-technologies-inc-filed-sec-form-8-k-submission-of-matters-6324157)
- 2025-12-06 00:23 UTC [SEC Form 4] [Director Davin Michael R received a gift of 3,212 shares, sold $4,918 worth of shares (3,212 units at $1.53) and gifted 3,212 shares, decreasing direct ownership by 73% to 1,206 units (SEC Form 4)](https://www.quantisnow.com/insight/director-davin-michael-r-received-a-gift-of-3212-shares-6305736)
- 2025-12-02 20:56 UTC [SEC Form 144] [SEC Form 144 filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-allurion-technologies-inc-6299474)
- 2025-11-26 21:18 UTC [SEC Form D] [SEC Form D filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-allurion-technologies-inc-6295260)
- 2025-11-25 22:09 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Allurion Technologies Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-allurion-technologies-inc-6293976)
- 2025-11-25 14:25 UTC [Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence](https://www.quantisnow.com/insight/allurion-announces-initial-results-on-combining-the-allurion-program-with-6293107)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ALUR
- Earnings history: https://www.quantisnow.com/earnings/ALUR
- Dividend history: https://www.quantisnow.com/dividends/ALUR
- Insider transactions: https://www.quantisnow.com/insiders/ALUR
- Options chain: https://www.quantisnow.com/options/ALUR
- SEC 8-K filings only: https://www.quantisnow.com/company/ALUR/8-k
- RSS and alerts for ALUR: https://www.quantisnow.com/docs/rss-feeds.md